Navigation Links
In Key Opinion Leader Management, Quantity Does Not Equal Quality in Evaluating a Scientist's Real Importance
Date:9/30/2009

ips with others in the community so their ideas may not be spread around as easily to peers and colleagues. If you're an isolated person, it's hard for ideas to flow. Conversely, there are people that companies might dismiss because there is not much evidence of their importance as measured by publication counts. But we find them highly connected in roles such as advisers and trusted colleagues, or subject matter experts to the community."

Lnx Pharma uses "social network analysis" to decipher the real relationships in the medical and pharmaceutical research communities. Applying their proprietary technology to the universe of people and publications, they found across multiple disease categories that 50% of potentially valuable key scientific leaders were actually not the most frequently published or cited scientists. That is to say, if pharmaceutical companies are only considering volume and popularity as a metric for evaluating key advisers, they are missing up to half of the people who may be truly of importance.

Analyzing over a dozen disease categories for clients who engage the company for custom research, Lnx Pharma consistently found many previously undervalued or unknown KOLs, but more importantly they uncovered critical information about how people work and organize around specific ideas and topics. Importance can't be reliably measured by a list using one or two ranking criteria. Lnx Pharma technology allows deciphering of the complex web of relationship in the ecosystem of human expert networks, identifying relative positions of individuals in the network, based on multiple highly relevant criteria. The results are critical not only for Key Opinion Leader management, but also for overall pharmaceutical marketing research.

"Many of our clients have
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
2. Alfacell Receives Going Concern Audit Opinion
3. Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
4. Kuvan Receives Positive Opinion From CHMP for European Approval
5. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
6. FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia
7. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
8. Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
9. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
10. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
11. Three Expert Opinion Journals now Publishing Original Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
In Key Opinion Leader Management, Quantity Does Not Equal Quality in Evaluating a Scientist's Real Importance
(Date:4/1/2015)... (PRWEB) April 01, 2015 The concept of ... a multi-billion dollar industry. Founder of Fasciology, Ashley Black, says ... area of fat, instead of having to wait for the ... claims that “ prior to fat cooling procedures, the ... or contouring, was liposuction, which is a highly invasive procedure.” ...
(Date:4/1/2015)... 2015 National recruitment firm Slone ... Brad Allen as Head of Sales at Optimal Medicine, ... market. , Allen brings over 20 years experience ... a number of companies including Dell Services Healthcare, Medsphere ... were a perfect fit for accomplishing the goals Optimal ...
(Date:3/31/2015)... JUNCTION, N.J., March 31, 2015 CytoSorbents ... company using blood purification to treat critically-ill and ... an operational summary and reports financial results for ... 2014 CytoSorb® product revenues were a ... compared to 2013 CytoSorb® revenues of $0.8M Highlights ...
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ - ESSA Pharma ... that it has filed with the Food and Drug ... ("IND") application related to the Company,s proposed clinical trial ... IND application is required in order for ESSA to ... The IND application is a complete description ...
Breaking Biology Technology:Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3Slone Partners Fills Head of Sales at Optimal Medicine 2CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4
... Mass., March 3 ETEX Corporation, an advanced,biomaterials ... a supply,agreement with LifeNet Health, Inc., Under ... Bone Matrix (DBM) powder to be mixed with ... substitute material called,EquivaBone(TM). ETEX will manufacture EquivaBone(TM) in ...
... Md., March 3 Iomai Corporation,(Nasdaq: IOMI ) ... 2007 financial results before the markets open and hold ... clinical progress,on Thursday, March 6, 2008 at 1:30 p.m. ... the live conference call on Thursday, March 6 at ...
... - BIKAM,pioneers in the discovery and development ... degenerative eye diseases and ocular disorders and,Dalton ... worldwide,collaboration and agreement to discover and develop ... Dalton Medicinal Chemistry will utilize their proprietary ...
Cached Biology Technology:ETEX and LifeNet Health, Inc. Enter Agreement 2Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6 2BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement 2
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
(Date:3/12/2015)... , March 12, 2015 The mascots ... Brenner Children,s Hospital, part of Wake Forest Baptist Medical ... initiative for the 2015 ACC Men,s Basketball Tournament. Young ... with them and getting their autographs. Brenner ... Baptist. It is the only children,s hospital in northwest ...
(Date:3/12/2015)... Calif. , March 12, 2015 WHEN:Tuesday, ... Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , ... Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... order to compete in several different markets and ... is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... drugs of abuse decrease the generation of new neurons ... this process, called neurogenesis, had not been clear. , ... advance of print publication of the November issue of ... from University of Saskatchewan show that a potent and ...
... a type of blue-green algae known as Nostoc, shows promise ... other neurodegenerative diseases, according to an in vitro study by ... time that a potent agent against Alzheimer's has been isolated ... published in the Dec. 26 issue of the Journal ...
... that has been used to track the source of ... may have some new uses: detecting rapidly growing cancers ... known as "stable isotope ratio mass spectrometry," can determine ... or isotopes of an element in the substance ?such ...
Cached Biology News:Natural compound from 'pond scum' shows potential activity against Alzheimer's 2War on terror meets war on cancer 2War on terror meets war on cancer 3War on terror meets war on cancer 4War on terror meets war on cancer 5War on terror meets war on cancer 6
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
Complexin-1/2 (FL-134)...
...
... Endothelin-1 (human, porcine) Endogenous ... endothelin ETA receptor and modulates vascular tonus. ... of three distinct endothelin genes. ET-2 and ... in two and six amino acids, respectively. ...
Biology Products: